NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
24.12
-0.07 (-0.29%)
At close: Sep 15, 2025, 4:00 PM EDT
24.12
0.00 (0.00%)
After-hours: Sep 15, 2025, 4:39 PM EDT
NAMS Employees
NewAmsterdam Pharma Company had 68 employees as of December 31, 2024. The number of employees increased by 39 or 134.48% compared to the previous year.
Employees
68
Change (1Y)
39
Growth (1Y)
134.48%
Revenue / Employee
$941,265
Profits / Employee
-$2,436,985
Market Cap
2.72B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 68 | 39 | 134.48% |
Dec 31, 2023 | 29 | 12 | 70.59% |
Dec 31, 2022 | 17 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NAMS News
- 11 days ago - NewAmsterdam Pharma Company N.V. (NAMS) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
- 21 days ago - NewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in September - GlobeNewsWire
- 25 days ago - Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal's Sellersville, Pennsylvania Site - PRNewsWire
- 4 weeks ago - NewAmsterdam Announces Acceptance of Marketing Authorization Applications for Review by European Medicine Agency for Obicetrapib - GlobeNewsWire
- 5 weeks ago - NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results - GlobeNewsWire
- 6 weeks ago - NewAmsterdam Pharma Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimer's Disease Biomarkers at AAIC 2025 - GlobeNewsWire
- 7 weeks ago - NewAmsterdam Pharma to Present Alzheimer's Biomarker Data from BROADWAY Trial at AAIC 2025 - GlobeNewsWire
- 3 months ago - NewAmsterdam Pharma Announces Positive Topline Alzheimer's Disease Data from BROADWAY Clinical Trial - GlobeNewsWire